The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization
Recent Posts
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
- Advanced Models Offer Scientists a Promising Tool to Better Understand Brain Disorders
- NJIT Computing Professor Zhi Wei Named Fellow of AAAS, Follows IEEE Honor.
- Alzheimer’s Early Detection Tests Using Video Games Could Be As Effective as Blood Tests and Boost Clinical Trials.
- Princeton joins new cancer research hub established with gift from Weill Family Foundation.
Categories
- Community (2,240)
- Covid (985)
- CTO Events (6)
- News (2,854)
- Pilots (21)